The connection between dyslipidemia and Alzheimer’s is not completely comprehended and that GLP-1 has been shown to protect against dyslipidemia (Patel et al., 2014, 2017, 2018; Jall et al., 2017) and promote neurogenesis (McGovern et al., 2012; Lennox et al., 2013; Bae and Song, 2017). Here, GCG is linked to metabolic syndrome.